EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 111 filers reported holding EPIZYME INC in Q2 2018. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,888,000 | +22.5% | 272,476 | +56.6% | 0.54% | +17.8% |
| Q2 2018 | $2,357,000 | -4.1% | 173,982 | +25.7% | 0.46% | -0.2% |
| Q1 2018 | $2,457,000 | -4.3% | 138,431 | -32.3% | 0.46% | -14.3% |
| Q4 2017 | $2,568,000 | -29.7% | 204,600 | +6.7% | 0.53% | -47.6% |
| Q3 2017 | $3,652,000 | +57.7% | 191,719 | +25.0% | 1.02% | +48.5% |
| Q2 2017 | $2,316,000 | – | 153,351 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |